Enterococcus

• 

  Subject Areas on Research

  • A case-control study of nosocomial ampicillin-resistant enterococcal infection and colonization at a university hospital. 
  • Addressing the Menace of Enterococcal Endocarditis. 
  • Bacteremia, central catheters, and neonates: when to pull the line. 
  • Bile-esculin test for presumptive identification of enterococci and streptococci: effects of bile concentration, inoculation technique, and incubation time. 
  • Blood culture contamination with Enterococci and skin organisms: implications for surveillance definitions of primary bloodstream infections. 
  • Co-infection or co-colonization with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a network of community hospitals. 
  • Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species. 
  • Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device. 
  • Development of a standardized screening method for detection of vancomycin-resistant enterococci. 
  • Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. 
  • Editorial commentary: NOVA score to predict endocarditis in patients with enterococcal bacteremia: sticking to valves or to scores? 
  • Effect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US. 
  • Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible Enterococcus spp. Bloodstream Infections. 
  • Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. 
  • Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. 
  • Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database. 
  • Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. 
  • Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia. 
  • Invasive gram-positive bacterial infection in cancer patients. 
  • Lactose drives Enterococcus expansion to promote graft-versus-host disease. 
  • Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem. 
  • Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci. 
  • Mutational analysis of potential zinc-binding residues in the active site of the enterococcal D-Ala-D-Ala dipeptidase VanX. 
  • Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. 
  • Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease. 
  • Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study. 
  • Sequential emergence of antibiotic resistance in enterococcal bloodstream isolates over 25 years. 
  • Survival of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus spp. for an extended period of transport. 
  • Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin. 
  • United States geographic bacteria susceptibility patterns. 1996 ASCP Susceptibility Testing Group. American Society of Clinical Pathologists. 
  • United States geographic bacteria susceptibility patterns. 1997 ASCP Susceptibility Testing Group. 
  • Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. 
  • Vancomycin-resistant enterococci: risk related to the use of intravenous vancomycin in a university hospital.